ClinicalTrials.Veeva

Menu

The Effects of Losartan on Social Reward

U

University of Electronic Science and Technology of China

Status

Unknown

Conditions

Healthy

Treatments

Drug: Losartan
Drug: Placebo Oral Tablet

Study type

Interventional

Funder types

Other

Identifiers

NCT04604756
UESTC-neuSCAN-72

Details and patient eligibility

About

The aim of the study is to investigate the effect of losartan (50mg, single dose) on social reward

Full description

In a double-blind, between-subject, placebo-controlled design the effects of a single dose of losartan (50mg) on social reward in healthy participants will be examined. 90 minutes after subjects administrate 50mg losartan or placebo, participants will undergo a social incentive delay task. Neural activity will be assessed by the acquisition of functional magnetic resonance imaging (fMRI) data.

Enrollment

90 estimated patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy subjects without past or current psychiatric or neurological disorders

Exclusion criteria

  • history of head injury
  • medical or psychiatric illness
  • hypertension

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 2 patient groups, including a placebo group

Losartan group
Experimental group
Description:
Drug: Losartan
Treatment:
Drug: Losartan
Placebo group
Placebo Comparator group
Description:
Drug: Placebo Oral Tablet
Treatment:
Drug: Placebo Oral Tablet

Trial contacts and locations

1

Loading...

Central trial contact

Weihua Zhao, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems